These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 15574268)
1. [Evolution of lung cancer in the North of the province of Castellón, Spain, 1993-2002]. Miravet L; Paradís A; Peláez S; Arnal M; Cabadés F Arch Bronconeumol; 2004 Dec; 40(12):553-7. PubMed ID: 15574268 [TBL] [Abstract][Full Text] [Related]
2. [Epidemiological study of lung cancer in the northern part of the province of Castellón]. Miravet L; Peláez S; Paradís A; Arnal M; Cabadés F Arch Bronconeumol; 2001 Sep; 37(8):298-301. PubMed ID: 11562314 [TBL] [Abstract][Full Text] [Related]
3. Lung cancer in a health area of Spain: incidence, characteristics and survival. Prim JM; Barcala FJ; Esquete JP; Reino AP; López AF; Cuadrado LV Eur J Cancer Care (Engl); 2010 Mar; 19(2):227-33. PubMed ID: 19709170 [TBL] [Abstract][Full Text] [Related]
4. [Lung cancer in Avila province, Spain. Incidence rates, epidemiolgy of the year 2012 and trends in the last 20 years]. Hernández-Hernández JR; Moreno de Vega-Herrero MB; Iglesias-Heras M; García-García R; Hernández-Terciado F; Celdrán-Gil J Semergen; 2015 Oct; 41(7):362-9. PubMed ID: 25193632 [TBL] [Abstract][Full Text] [Related]
5. [Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series]. Santos-Martínez MJ; Curull V; Blanco ML; Macià F; Mojal S; Vila J; Broquetas JM Arch Bronconeumol; 2005 Jun; 41(6):307-12. PubMed ID: 15989887 [TBL] [Abstract][Full Text] [Related]
6. [Evolution of the incidence and survival of bronchogenic carcinoma in the province of Castellón (Spain) from 2004 to 2017.]. Miravet Sorribes LM; Montoliu Nebot J; Iradi Casal A; Carrera Hueso FJ; Arnedo Pena A Rev Esp Salud Publica; 2023 Jun; 97():. PubMed ID: 37325902 [TBL] [Abstract][Full Text] [Related]
7. An attempt to use the WHO typing in the histological classification of lung carcinomas. Reinilä A; Dammert K Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):783-90. PubMed ID: 4447006 [No Abstract] [Full Text] [Related]
8. Pretreatment classification and staging of bronchogenic carcinoma. Larsson S Scand J Thorac Cardiovasc Surg Suppl; 1973; ():1-147. PubMed ID: 4358671 [No Abstract] [Full Text] [Related]
9. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y; J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209 [TBL] [Abstract][Full Text] [Related]
10. Lung and bronchus cancer in Puerto Rico: changes in incidence and mortality rates by histology and sex during 1987-2003. Rivas H; Laureano AF; Serrano J; Nazario CM P R Health Sci J; 2011 Dec; 30(4):176-81. PubMed ID: 22263297 [TBL] [Abstract][Full Text] [Related]
11. Hazard Ratio of Smoking on Lung Cancer in Korea According to Histological Type and Gender. Yun YD; Back JH; Ghang H; Jee SH; Kim Y; Lee SM; Samet JM; Lee KS Lung; 2016 Apr; 194(2):281-9. PubMed ID: 26718701 [TBL] [Abstract][Full Text] [Related]
12. [Incidence of bronchopulmonary carcinoma in Castilla-León in 1997. Multicenter study of the Society of Castilla-León of Respiratory Pathology (SOCALPAR). Study Group for Bronchopulmonary Carcinoma of the SOCALPAR]. Arch Bronconeumol; 2000 Jun; 36(6):313-8. PubMed ID: 10932340 [TBL] [Abstract][Full Text] [Related]
13. Patho-epidemiology of lung cancer in Karachi (1995-2002). Bhurgri Y; Bhurgri A; Usman A; Sheikh N; Faridi N; Malik J; Ahmed R; Kayani N; Pervez S; Hasan SH Asian Pac J Cancer Prev; 2006; 7(1):60-4. PubMed ID: 16629517 [TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking and trends in lung cancer incidence in Lithuania: an analysis by histological type. Everatt R; Kuzmickienė I; Senulis A Medicina (Kaunas); 2011; 47(4):222-9. PubMed ID: 21829055 [TBL] [Abstract][Full Text] [Related]
15. [Lung cancer in Spain. Current epidemiology, survival, and treatment]. Escuín JS Arch Bronconeumol; 2009 Jul; 45(7):341-8. PubMed ID: 19324488 [TBL] [Abstract][Full Text] [Related]
16. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada. Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240 [TBL] [Abstract][Full Text] [Related]
17. [Characteristics of lung cancer in a region in northern Spain]. Alonso-Fernández MA; García-Clemente M; Escudero-Bueno C; Arch Bronconeumol; 2005 Sep; 41(9):478-83. PubMed ID: 16194509 [TBL] [Abstract][Full Text] [Related]
18. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm. Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557 [TBL] [Abstract][Full Text] [Related]
19. Lung cancer incidence in the province of Avila, Spain in 2002 and decade-long trends. Hernández Hernández JR; Tapias del Pozo JA; Moreno Canelo P; Rodríguez Puebla A; Paniagua Tejo S; Sánchez Marcos JC Arch Bronconeumol; 2004 Jul; 40(7):304-10. PubMed ID: 15225516 [TBL] [Abstract][Full Text] [Related]
20. Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study. Linares I; Molina-Portillo E; Expósito J; Baeyens JA; Suárez C; Sánchez MJ Clin Transl Oncol; 2016 May; 18(5):489-96. PubMed ID: 26329296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]